Addressing Threats to the United States by the Government of Iran

Risks & Considerations

• The Executive Order establishes a mechanism to impose additional ad valorem duties (example: 25%) on imports that are products of any country found to directly or indirectly purchase goods or services from Iran. This creates a new, potentially wide-reaching tariff lever that can be applied dynamically based on determinations by the Department of Commerce and subsequent recommendations by the Secretary of State.
• For Vanderbilt, the primary risk is increased cost and volatility in global supply chains for research equipment, laboratory reagents, medical supplies, and specialty materials that are sourced from or routed through countries that could be designated under the EO. Even goods that merely have an origin traceable to Iran via intermediaries may be subject to additional duties.
• Compliance and monitoring burden will increase. The EO delegates broad authority to Commerce, State, Treasury, DHS, and the U.S. Trade Representative to make determinations and issue implementing rules, creating uncertainty for procurement, import classification, and contract performance. University procurement, export-control, and legal teams will face new due‑diligence requirements to identify country-of-origin risks and potential indirect links to Iran.
• There is a risk of retaliatory measures by affected countries or trade partners, which could trigger broader trade disruptions, increases in U.S. export costs, or obstacles for international collaborations and partnerships. That could affect donor relationships, research collaborations, and student/faculty mobility in certain regions.
• The EO’s definition of “indirectly” (acquisitions through intermediaries or third countries where origin can reasonably be traced to Iran) increases uncertainty: suppliers that rely on globalized supply chains may become higher risk even if final production occurs outside Iran. This can result in sudden tariff application and procurement delays if a supplier or country is designated.
• While the EO is targeted at addressing national-security concerns tied to Iran, its broad trade-tool approach means academic activities with international dimensions (e.g., collaborative research, university-operated overseas programs, and global procurement) could be affected indirectly even though the university itself is not a sanctions target.

Impacted Programs

• Vanderbilt University Medical Center (VUMC) — high volume procurement of medical equipment, reagents, and specialized supplies may face price increases, delivery delays, or supplier requalification if goods are subject to additional duties.
• School of Engineering and Research Laboratories — imported specialized materials, components for lab equipment, and collaborative projects with international industry partners could see cost and timeline impacts.
• Global Education Office & International Programs (including UAE partnerships) — program costs, partner-country relations, and student/faculty exchange logistics could be indirectly affected if partner countries are designated or if economic retaliation affects those partners’ ability to host or fund programs.
• Procurement, Contracts & Supply Chain Management — will need to manage increased vendor vetting, country-of-origin tracking, and possible renegotiation of terms and tariffs clauses.
• Office of Research & Sponsored Programs — grant budgets and timelines that assume certain equipment or materials procurement costs may need adjustment; sponsor approvals or re-budgeting could be required.
• Office of General Counsel & Export Control/Compliance — increased workload to interpret implementing regulations, ensure compliance with IEEPA-related measures, and advise on mitigation and licensing options.

Financial Impact

• Direct cost increases for imported goods subject to additional duties (example scenario: a 25% tariff) could materially raise capital and operating expenses for labs and clinical operations that rely on imported items.
• Research budgets and grant awards may not cover unexpected tariff-driven cost increases, requiring re-budgeting, internal subsidy, or reductions in scope. This could slow research progress or increase institutional cost-sharing obligations.
• Higher procurement costs and supply-chain disruption risk can increase project contingency needs across capital projects (e.g., lab build-outs) and sponsored programs, impacting short- and medium-term cash flow planning.
• Potential downstream effects on international fundraising or partnerships if partner-country economies are affected by trade measures or retaliation; some donors or collaborators may face reduced capacity to support joint initiatives.

Operational & Compliance Considerations

• Need to inventory and map suppliers and product origins for high-risk categories (medical supplies, lab reagents, specialized equipment, and manufactured components) to identify exposure to countries that might be designated under the EO.
• Increased customs and tariff complexity — procurement and logistics teams will need updated protocols to capture accurate country-of-origin information and to assess whether goods are “products of” a given foreign country for tariff purposes.
• Potential requirement to engage legal counsel or request licenses/waivers from Treasury/Commerce for certain transactions; coordination with federal agencies may be necessary for education-related imports or sanctioned supplier issues.
• Monitoring requirement — the Secretary of Commerce and Secretary of State will continually assess foreign-country dealings with Iran; Vanderbilt must plan for dynamic, potentially sudden policy changes that could affect ongoing contracts and shipping pipelines.

Mitigation Recommendations

• Immediate supplier risk assessment: prioritize critical supply lines (VUMC, key research labs) and request full chain-of-custody/country-of-origin documentation from vendors.
• Expand procurement alternatives: identify domestic or allied-country suppliers, pre-qualify secondary suppliers, and consider inventory buffers for essential consumables where feasible.
• Budget contingencies: instruct research administrators and PIs to review active grants for exposure and consult sponsors early to plan for allowable re-budgeting or scope adjustments.
• Legal and compliance posture: engage Office of General Counsel and Export Control to interpret forthcoming Commerce/State implementing rules, and prepare procedures for licensing requests or exemptions where appropriate.
• Communications & scenario planning: develop internal guidance for procurement, research administration, and international program staff; run scenario exercises (designation of a partner country, retaliatory tariffs) to test response plans.
• Advocacy: coordinate with peer institutions and trade/education associations to monitor rulemaking, submit comments, and seek clarifying guidance from agencies regarding university-specific activities and exemptions.

Relevance Score: 3 (Moderate risks — compliance and operational adjustments are likely required; financial impacts depend on supplier exposure and tariff magnitude.)